Cargando…

Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study

INTRODUCTION: There are data suggesting that the diagnostic usefulness of faecal calprotectin (FC) may vary depending on the Crohn's disease (CD) location. The aim of the study was to compare the diagnostic usefulness of FC in CD patients with different disease locations. MATERIAL AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stawczyk-Eder, Kamila, Eder, Piotr, Lykowska-Szuber, Liliana, Krela-Kazmierczak, Iwona, Klimczak, Katarzyna, Szymczak, Aleksandra, Szachta, Patrycja, Katulska, Katarzyna, Linke, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424241/ https://www.ncbi.nlm.nih.gov/pubmed/25995752 http://dx.doi.org/10.5114/aoms.2014.43672

Ejemplares similares

The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn’s disease activity
por: Eder, Piotr, et al.
Publicado: (2015)

Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn’s disease treated with anti-tumor necrosis factor antibodies
por: Eder, Piotr, et al.
Publicado: (2015)

Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn’s disease naive to anti-TNF agents
por: Eder, Piotr, et al.
Publicado: (2015)

Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn’s disease
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2015)

Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

Disturbances in apoptosis of lamina propria lymphocytes in Crohn's disease
por: Eder, Piotr, et al.
Publicado: (2015)

Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2014)

Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2023)

Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2021)

Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?
por: Krela-Kazmierczak, Iwona, et al.
Publicado: (2018)

ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s Disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2019)

Diet and Nutritional Factors in Male (In)fertility—Underestimated Factors
por: Skoracka, Kinga, et al.
Publicado: (2020)

Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?
por: Walczak, Michal, et al.
Publicado: (2020)

Dietary Support in Elderly Patients with Inflammatory Bowel Disease
por: Eder, Piotr, et al.
Publicado: (2019)

Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)—A Narrative Review
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2021)

Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver Injury
por: Lubarska, Marta, et al.
Publicado: (2023)

Current management of anal fistulas in Crohn's disease
por: Hermann, Jacek, et al.
Publicado: (2015)

What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2021)

Bone Metabolism and the c.-223C > T Polymorphism in the 5′UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2016)

Why Does Obesity as an Inflammatory Condition Predispose to Colorectal Cancer?
por: Rychter, Anna Maria, et al.
Publicado: (2023)

Multidimensional Disadvantages of a Gluten-Free Diet in Celiac Disease: A Narrative Review
por: Marciniak, Martyna, et al.
Publicado: (2021)

A Vicious Cycle of Osteosarcopenia in Inflammatory Bowel Diseases—Aetiology, Clinical Implications and Therapeutic Perspectives
por: Skrzypczak, Dorota, et al.
Publicado: (2021)

Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota—A Narrative Review
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2022)

Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence
por: Baillet, Pierre, et al.
Publicado: (2018)

Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease
por: Rychter, Anna Maria, et al.
Publicado: (2021)

Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis
por: Bathe, Anna Luisa, et al.
Publicado: (2019)

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis
por: Bohra, Anuj, et al.
Publicado: (2023)

Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications
por: Skrzypczak, Dorota, et al.
Publicado: (2021)

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease
por: e Penna, Francisco Guilherme Cancela, et al.
Publicado: (2020)

Faecal calprotectin concentration in children with coeliac disease
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2020)

Guidance on the interpretation of faecal calprotectin levels in children
por: Orfei, Martina, et al.
Publicado: (2021)

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
por: Bromke, Mariusz A., et al.
Publicado: (2021)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients
por: Łodyga, Michał, et al.
Publicado: (2021)

Usefulness of Endoscopic Indices in Determination of Disease Activity in Patients with Crohn's Disease
por: Kucharski, Marcin, et al.
Publicado: (2016)

Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn’s Disease
por: Mendall, Michael A., et al.
Publicado: (2016)

Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin
por: Roberts, Rebecca L., et al.
Publicado: (2018)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Faecal calprotectin indicates intestinal inflammation in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_50ej12kckgtsthb44j0tej6v3h